May 14, 2023
Q1 2023
Summary / Key Findings:
  • Results were reported from 7 sites across the United States
  • Geographical differences were observed for opioids, poly-drug use, NPS and xylazine
  • Fentanyl overwhelming remains the most commonly detected opioid nationally
  • Numerous NPS were detected, including fluorofentanyl, bromazolam, clonazolam, various synthetic cannabinoids, and more
DOWNLOAD THE REPORT